CCL19 and Sjogren syndrome: Interestingly, in addition to its pathogenic role, this pathway can be exploited as a biomarker of disease as we showed that LTα expression correlates with CCL19 levels and distinguishes patients with autoimmunity and dryness (Sjögren’s syndrome) from patients with dryness only (sicca patients).